Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Major Declines in Epoetin Dosing after Prospective Payment System Based on Dialysis Facility Organizational Status
15
Zitationen
6
Autoren
2014
Jahr
Abstract
Historically, important differences in anemia management were evident by dialysis organizational status. However, the confluence of financial incentives bundling epoetin payments and mounting scientific evidence linking higher hematocrit targets and higher epoetin doses to adverse outcomes have culminated in lower access to epoetin and lower doses across all dialysis providers in the first year after PPS.
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 22.029 Zit.
Anemia of Chronic Disease
2005 · 3.699 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.732 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.167 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.088 Zit.